SEC Form 4 · accession 0001582945-16-000010
CEREBAIN BIOTECH CORP. · CBBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wesley D. Tate
Officer — Chief Financial Officer · Director
Period of report
Dec 15, 2015
Accepted (ET)
Jun 15, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453099
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2015 | A | 150,000 | $0.27 | A | 472,203 | D | |
| Common StockF2 | Jan 27, 2016 | A | 150,000 | $0.30 | A | 622,203 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person was issued the shares from the Issuer in lieu of compensation for services valued at $40,500.
- F2The Reporting Person was issued the shares from the Issuer in lieu of a payable conversion of $45,000.